公众对神经技术的看法 用于准情绪,记忆和运动症状
medRxiv : the preprint server for health sciences
|July 1, 2024
概括
公众对神经技术的态度各不相同. 像深度大脑刺激 (DBS) 这样的侵入性治疗被认为更有风险,而运动症状比情绪症状更容易接受治疗.
科学领域:
- 神经科学是一个神经科学.
- 医疗技术 医疗技术 医学技术
- 公共卫生 公共卫生
背景情况:
- 神经技术为大脑疾病提供了革命性的治疗方法.
- 鉴于神经外科的历史关注,公众的接受对于伦理创新至关重要.
- 了解公众的看法是克服采用障碍的关键.
研究的目的:
- 调查公众对四种神经技术的态度:深度大脑刺激 (DBS),跨脑磁刺激 (TMS),药片和MRI引导的聚焦超声波 (MRgFUS).
- 评估风险,益处,侵入性,可接受性和情绪,记忆和运动症状的个人兴趣的看法.
- 确定公众愿意采用这些技术来缓解症状.
主要方法:
- 全国代表性样本1052名美国成年人参与.
- 参与者评估了四种神经技术,用于治疗情绪,记忆或运动症状.
- 调查测量了对风险,益处,侵入性,可接受性和个人利益的看法.
主要成果:
- 深度大脑刺激 (DBS) 被认为是最具入侵性和风险的,导致个人身份的最大变化.
- 对运动症状的神经调节被视为比对记忆或情绪症状更有益,更可接受,更有可能被使用.
- 手术侵入性神经技术 (DBS,MRgFUS) 被认为比非侵入性技术更有风险,更难接受.
结论:
- 人们对神经技术的接受程度受其侵袭性和所治疗的症状类型的影响.
- 与身体 (运动) 症状相比,人们更不愿意使用神经调节来治疗心理 (情绪) 症状.
- 伦理发展和公众参与对于成功将神经技术纳入临床实践至关重要.
更多相关视频
07:12Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
3.5K
14:47Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
Published on: April 21, 2023
2.6K
相关概念视频
Brain Imaging
225
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
225
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
118
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
118
